Cost-benefit analysis of smoking in Latvia

Anita Kokarevica, Anastasija Ludzeniece

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

One of 3 persons in Latvia is a smoker. Smoking has been proved to be linked to different cancer, cardiovascular and respiratory diseases. The overall purpose of the study addresses smoking as a cost-benefit subject in Latvian state economy. A model to perform evidence-based cost-benefit analysis (CBA) was developed highlighting direct and indirect costs borne by the state, smokers and second-hand smokers. The paper envisages the approach to building the model. As the first study on economic impact of smoking in Latvia, the CBA results demonstrate substantial excess of financial benefits from smoking citizens in Latvia. Authors discuss the smoking attributable fraction (SAF) eligibility and needs in data to discover the full impact of smoking on health and non-health aspects
Original languageEnglish
Title of host publicationSHS Web of Conferences
EditorsL. Vilka, J. Vike
Volume85
ISBN (Electronic)978-2-7598-9112-2
DOIs
Publication statusPublished - 2020
Event7th International Interdisciplinary Scientific Conference SOCIETY. HEALTH. WELFARE
- Riga, Latvia
Duration: 10 Oct 201812 Oct 2018
Conference number: 7

Conference

Conference7th International Interdisciplinary Scientific Conference SOCIETY. HEALTH. WELFARE
Country/TerritoryLatvia
CityRiga
Period10/10/1812/10/18

Keywords*

  • CBA
  • smoking
  • costs
  • benefits

Field of Science*

  • 3.3 Health sciences

Publication Type*

  • 3.2. Articles or chapters in other proceedings other than those included in 3.1., with an ISBN or ISSN code

Fingerprint

Dive into the research topics of 'Cost-benefit analysis of smoking in Latvia'. Together they form a unique fingerprint.

Cite this